Peyman Hadji
- Orthopedics and Sports Medicine top 0.2%
- Bone health and osteoporosis research 45
- Bone and Joint Diseases 15
- Family Practice top 0.5%
- Oncology top 0.5%
- Bone health and treatments 93
- Cancer Diagnosis and Treatment 15
- Cancer Research top 2%
- Breast Cancer Treatment Studies 19
- Genetics top 1%
- Estrogen and related hormone effects 58
-
- Radiopharmaceutical Chemistry and Applications 22
-
- Bone Metabolism and Diseases 14
- Co-authors
- Robert E. ColemanMatti AaproJean‐Jacques BodyMatthias KalderMichael GnantVolker ZillerAllan LiptonJørn Herrstedt
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Peyman Hadji
155 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Orthopedics and Sports Medicine 1.7k
- Family Practice 381
- Oncology 3.9k
- Cancer Research 769
- Genetics 1.2k
Countries citing papers authored by Peyman Hadji
This map shows the geographic impact of Peyman Hadji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peyman Hadji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peyman Hadji more than expected).
Fields of papers citing papers by Peyman Hadji
This network shows the impact of papers produced by Peyman Hadji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peyman Hadji. The network helps show where Peyman Hadji may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peyman Hadji, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Bone health in cancer: ESMO Clinical Practice Guidelinesbreakdown → | 2020 | 294 |
| 2 | 2016 | 45 | |
| 3 | 2016 | 33 | |
| 4 | 2016 | 73 | |
| 5 | Evolution of subject characteristics in FREEDOM and its extension for up to 8 years | 2015 | 2 |
| 6 | 2015 | 11 | |
| 7 | 2015 | 43 | |
| 8 | 2014 | 26 | |
| 9 | 2014 | 12 | |
| 10 | 2013 | 77 | |
| 11 | 2013 | 73 | |
| 12 | 2012 | 21 | |
| 13 | 2012 | 1 | |
| 14 | 2011 | 264 | |
| 15 | 2009 | 220 | |
| 16 | 2009 | 65 | |
| 17 | 2008 | 436 | |
| 18 | Monthly ibandronate improves persistence vs. weekly bisphosphonates after 9 months of treatment | 2007 | 1 |
| 19 | 2001 | 3 | |
| 20 | 2000 | 40 |
About Peyman Hadji
Peyman Hadji is a scholar working on Orthopedics and Sports Medicine, Oncology and Family Practice, having authored 167 papers that have together received 5.8k indexed citations. Recurring topics across this work include Bone health and treatments (93 papers), Estrogen and related hormone effects (58 papers), Bone health and osteoporosis research (45 papers), Radiopharmaceutical Chemistry and Applications (22 papers), Breast Cancer Treatment Studies (19 papers), Cancer Diagnosis and Treatment (15 papers), Bone and Joint Diseases (15 papers) and Bone Metabolism and Diseases (14 papers). The work is most often cited by research in Orthopedics and Sports Medicine (1.7k citations), Family Practice (381 citations) and Oncology (3.9k citations). Peyman Hadji has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Robert E. Coleman, Matti Aapro, Jean‐Jacques Body, Matthias Kalder, Michael Gnant, Volker Ziller, Allan Lipton, Jørn Herrstedt, Ioannis Kyvernitakis and Lorenz C. Hofbauer. Their work appears in journals such as The Lancet, JAMA and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.